Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2025 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2025 Earnings Call Transcript May 6, 2025Esperion Therapeutics, Inc. misses on earnings expectations.
Posts Tagged ‘NASDAQ:ESPR’
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2024 Earnings Call Transcript March 4, 2025Esperion Therapeutics, Inc. beats earnings expectations.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call Transcript November 7, 2024Esperion Therapeutics, Inc. beats earnings expectations.
7 Best NASDAQ Stocks Under $5
A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript August 12, 2024Esperion Therapeutics, Inc. misses on earnings expectations.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
Should You Sell Esperion Therapeutics (ESPR)?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.
5 Hot Penny Stocks To Buy According to Hedge Funds
In this article, we will take a look at the 5 Hot Penny Stocks To Buy According to Hedge Funds.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to Esperion Therapeutics Third Quarter 2023 financial results call.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2023 Earnings Call Transcript
Alexis: Sheldon Koenig - President and Chief Executive Officer Eric Warren - Chief Commercial Officer Benjamin Halladay - Chief Financial Officer JoAnne Foody - Chief Medical ...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. Please be advised that today's conference call may be recorded.
10 Pharmaceutical Stocks to Buy Now According to Billionaire Kerr Neilson
In this article, we will look at 10 pharmaceutical stocks to buy now according to billionaire Kerr Neilson.
10 Best Stocks To Buy For Beginners Right Now
In this article, we discuss 10 best stocks to buy for beginners right now.
5 Small-Cap Stocks to Buy According to Australian Billionaire Kerr Neilson
In this article, we discuss the top 5 small-cap stocks to buy according to Australian Billionaire Kerr Neilson.
10 Best Healthcare Stocks to Buy According to Matthew Halbower’s Pentwater Capital Management
In this article, we discuss the 10 best healthcare stocks to buy according to Matthew Halbower's Pentwater Capital Management.
10 Best High Short Interest Stocks to Buy Now
In this article, we discuss the 10 best high short interest stocks to buy now.
Esperion Therapeutics, Inc. (ESPR): Are Hedge Funds Right About This Stock?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Is It Too Late to Buy Esperion Therapeutics (ESPR) Stock?
Wasatch Micro Cap Value Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Is Esperion Therapeutics (ESPR) a Smart Long-term Buy?
Wasatch Micro Cap Fund recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Is Esperion Therapeutics (ESPR) Stock a Buy For 2021?
Baron Discovery Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Is ESPR A Good Stock To Buy Now?
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Should Value Investors Buy Esperion Therapeutics (ESPR) Stock?
Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Do Hedge Funds Love Esperion Therapeutics (ESPR)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Were Hedge Funds Right About Betting On Esperion Therapeutics (ESPR)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Esperion Therapeutics, Inc. (ESPR): Hedge Funds Are Getting Bullish
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Were Hedge Funds Right About Selling Esperion Therapeutics (ESPR)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Did Hedge Funds Drop The Ball On Esperion Therapeutics (ESPR) ?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Should You Buy Esperion Therapeutics, Inc. (ESPR)?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Hedge Fund and Insider Trading News: David Einhorn, Caxton Associates, Crown Castle International Corp (CCI), Esperion Therapeutics Inc (ESPR), and More
David Einhorn sniffed out fixed income trouble in 2008 and sees more ahead in the US corporate bond market. In fact, the hedge fund chieftain is shorting corporate debt.
Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy?
The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive...
Here’s What Hedge Funds Think About Esperion Therapeutics, Inc. (ESPR)
How do we determine whether Esperion Therapeutics, Inc.
Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Hedge Fund and Insider Trading News: Jonathan Litt, Mike Novogratz, The Medicines Company (MDCO), Checkpoint Therapeutics Inc (CKPT), Koppers Holdings Inc. (KOP), and More
Nov 28 (Reuters) - Activist investor Jonathan Litt on Wednesday renewed call for the sale of the Saks Fifth Avenue brand, while asking owner Hudson’s Bay Co to make new board...
Hedge Fund and Insider Trading News: Crispin Odey, Cerrano Capital, WideOpenWest Inc (WOW), Constellation Pharmaceuticals Inc (CNST), Caesars Entertainment Co. (CZR), and More
LONDON (Reuters) - Sterling and UK government bonds will fall further in the run-up to Brexit, even after the pound slumped this week to its lowest in almost a year, prominent...
Hedge Fund and Insider Trading News: Elliot Management, Brevan Howard, Acorda Therapeutics Inc (ACOR), Cognizant Technology Solutions Corp (CTSH), and More
Elliott Management Corp., the hedge fund founded by billionaire Paul Singer, has built a stake in Sky Plc as shareholders prepare to vote on 21st Century Fox Inc.’s 11.7-billion...
Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.
Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging
Although the broader markets are relatively calm, five stocks, Nektar Therapeutics (NASDAQ:NKTR), Advanced Micro Devices, Inc.
Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks?
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc.
What’s Next For Esperion Therapeutics Inc (ESPR)?
Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unrelated to its own operations...
Esperion Therapeutics Inc (ESPR): Smart Money Doubles Down
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Beleaguered Esperion Therapeutics Inc. (ESPR) and Two Other Struggling Companies Register Insider Buying
While most investors and analysts tend to ignore insider selling completely, insider buying is believed to be extremely informative and crucially important, and rightly so.
Insider Buying Shines Spotlight on 3 Stocks That Look Cheap
The question most investors do not have an answer to is whether the recent downfall in U.S equities will be short-lived or will mark the beginning of a longer-term bear market...
Why Are These Healthcare Stocks Making Big Moves Today?
The week’s trading is underway and several biotech stocks are hot out of the gates, making big early morning gains.
See Which of These Three Tuesday Losers Hedge Funds Say You Should Buy on the Dip
It seems that the U.S.
